In this video, Fool.com contributors John Reeves and David Meier sit down and talk about the two biggest holdings in David's portfolio. He shares with investors how his investing style has shifted over the years, and why InvenSense (INVN) and Infinera (INFN 1.29%) both represent incredible disruptive opportunities, and why he sees them as two of the next great companies on the market.
Free Article
My Top Two Stocks: InvenSense and Infinera
By David Meier and John Reeves
–
Mar 8, 2013 at 4:57PM
NYSE: INVN
InvenSense, Inc.
Fool analyst David Meier shares with investors why these two stocks are at the top of his portfolio.
David Meier owns shares of MAKO Surgical, InvenSense, and Infinera. John Reeves has no position in any stocks mentioned. The Motley Fool recommends Infinera and MAKO Surgical. The Motley Fool owns shares of Infinera and InvenSense. The Motley Fool is short InvenSense. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.